Not a good buy right now: price trend is still decisively bearish (bearish moving-average stack + weakening MACD).
Even though the stock is near support and technically “oversold-ish,” there is no Intellectia buy signal to justify chasing a bounce for an impatient entry.
Options positioning is very call-heavy (bullish speculation), but that alone is not enough to override the downtrend and weak profitability trends.
Best stance now: hold/avoid new buys until price reclaims the pivot (~1.035) and momentum stabilizes.
Activity: Today’s option volume (474) is far below 5D/10D average volumes (~7.6k–7.9k), so the bullish skew is not backed by heavy participation today.
Positioning size: Call OI 68,944 vs Put OI 9,677 → market positioning favors upside exposure.
Volatility: Very high (30D IV ~141.83; HV ~103.53). IV percentile ~54 suggests elevated but not extreme relative to its recent range.
Takeaway: Options lean bullish, but not a strong “timing” confirmation given weak price trend and low current volume vs averages.
Technical Summary
Sell
7
Buy
4
Positive Catalysts
with short-term RSI deeply low.
Neutral/Negative Catalysts
Downtrend is intact: bearish moving-average structure + MACD deterioration argues against buying “right now.”
No supportive news flow in the last week (no fresh catalyst to reverse sentiment).
High volatility environment increases the chance of sharp drawdowns if support breaks.
Pattern-based outlook remains slightly negative over day/week/month horizons.
Earnings risk: with expected EPS still negative (Est. -0.0900), disappointment could pressure the stock further.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: 15.278M, up +238.01% YoY (strong top-line growth signal).
Profitability: Net income -15.419M (still deeply negative); EPS -0.08 (worse YoY).
Margins: Gross margin fell to 15.04 (major deterioration YoY), indicating scaling/profit conversion is not yet improving.
Bottom line: Growth is improving, but the business is not showing clean operating leverage yet—fundamentals don’t currently support buying aggressively into a downtrend.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Goldman Sachs (2025-11-26): Kept Buy rating but cut price target to $2 from $2.50.
Wall Street pro view (pros): Continued Buy suggests belief in longer-term upside and commercialization progress.
Wall Street pro view (cons): The price target cut signals tempered conviction/near-term execution risk; combined with weak margin/EPS trends, the “Buy” is more long-duration than timing-friendly.
Influential trading check: No recent congress trading data available; hedge funds and insiders are neutral with no notable recent trend.
Wall Street analysts forecast INVZ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INVZ is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast INVZ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INVZ is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Buy
Hold
Sell
0
Current: 0.896
Low
0
Averages
0
High
0
0
Current: 0.896
Low
0
Averages
0
High
0
Goldman Sachs
Buy
downgrade
$2
AI Analysis
2025-11-26
Reason
Goldman Sachs
Price Target
$2
AI Analysis
2025-11-26
downgrade
Buy
Reason
Goldman Sachs lowered the firm's price target on Innoviz Technologies to $2 from $2.50 and keeps a Buy rating on the shares.
Goldman Sachs
Neutral -> Buy
upgrade
2025-09-28
Reason
Goldman Sachs
Price Target
2025-09-28
upgrade
Neutral -> Buy
Reason
Goldman Sachs upgraded Innoviz Technologies to Buy from Neutral with a price target of $2.50, up from $1.50. The firm cites the company's design potential over the next six months and its \"inexpensive\" valuation for the upgrade. Autonomous technology is increasingly important for the car makers, which will drive a higher level of advanced driver assistance system program awards, the analyst tells investors in a research note. Goldman believes Innoviz is well positioned to benefit. A design win could be a positive catalyst for the stock, it says.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for INVZ
